Evidence map›Paper›PMID 30261916›Full record

ArticleAlzheimer's research & therapy2018

Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.

Susanne Ostrowitzki, Robert A Lasser, Ernest Dorflinger, Philip Scheltens, Frederik Barkhof, Tania Nikolcheva, Elizabeth Ashford, Sylvie Retout, Carsten Hofmann, Paul Delmar and 8 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Alzheimer's research & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Susanne OstrowitzkiProduct Development, Neuroscience, Genentech Inc., South San Francisco, CA, USA.
Robert A LasserMedDay Pharmaceuticals, Boston, MA, USA.
Ernest DorflingerFormerly Roche Translational & Clinical Research Center, New York, NY, USA.
Philip ScheltensVU University Medical Center, Amsterdam, The Netherlands.
Frederik BarkhofVU University Medical Center, Amsterdam, The Netherlands.
Tania NikolchevaRoche Pharma Research and Early Development, NORD, Basel, Switzerland.
Elizabeth AshfordRoche Products Limited, Welwyn Garden City, UK.
Sylvie RetoutRoche Pharma Research and Early Development, Clinical Pharmacology, Roche Innovation Center, Basel, Switzerland.
Carsten HofmannRoche Pharma Research and Early Development, Clinical Pharmacology, Roche Innovation Center, Basel, Switzerland.
Paul DelmarClinical Pharmacology and Bioanalytical R&D, Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Gregory KleinRoche Pharma Research and Early Development, NORD, Basel, Switzerland.
Mirjana AndjelkovicRoche Pharma Research and Early Development, Clinical Pharmacology, Roche Innovation Center, Basel, Switzerland.
Bruno DuboisAlzheimer Institute and ICM, UMR-S975, Salpêtrière University Hospital, AP-HP, Pierre and Marie Curie University, Paris, France.
Mercè BoadaResearch Center and Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain.
Kaj BlennowResearch Center and Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain.
Luca SantarelliFormerly Roche Pharma Research and Early Development, NORD, Basel, Switzerland.
Paulo FontouraClinical Pharmacology and Bioanalytical R&D, Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland. paulo.fontoura@roche.com.
SCarlet RoAD Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following publication of the original article [1], the author reported errors in the formatting of the table. The details of the errors are as follows.

Identifiers

PMID30261916
PMCPMC6158837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.